1. PREVAIL IV: A Randomized, Double-Blind, 2-Phase, Phase 2 Trial of Remdesivir vs Placebo for Reduction of Ebola Virus RNA in the Semen of Male Survivors. (12th March 2021) Authors: Higgs, Elizabeth S; Gayedyu-Dennis, Dehkontee; Fischer II, William A; Nason, Martha; Reilly, Cavan; Beavogui, Abdoul Habib; Aboulhab, Jamila; Nordwall, Jacqueline; Lobbo, Princess; Wachekwa, Ian; Cao, Huyen; Cihlar, Tomas; Hensley, Lisa; Lane, H Clifford Journal: Clinical infectious diseases Issue: Volume 73:Number 10(2021) Page Start: 1849 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗